<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">BR</journal-id>
<journal-title-group>
<journal-title>Biomedical Reports</journal-title></journal-title-group>
<issn pub-type="ppub">2049-9434</issn>
<issn pub-type="epub">2049-9442</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/br.2014.306</article-id>
<article-id pub-id-type="publisher-id">br-02-05-0644</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject></subj-group></article-categories>
<title-group>
<article-title>Cell culture of human gingival fibroblasts, oral cancer cells and mesothelioma cells with serum-free media, STK1 and STK2</article-title></title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>TSUGENO</surname><given-names>YUTA</given-names></name><xref rid="af1-br-02-05-0644" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>SATO</surname><given-names>FUYUKI</given-names></name><xref rid="af1-br-02-05-0644" ref-type="aff">1</xref><xref rid="af2-br-02-05-0644" ref-type="aff">2</xref><xref ref-type="corresp" rid="c1-br-02-05-0644"/></contrib>
<contrib contrib-type="author">
<name><surname>MURAGAKI</surname><given-names>YASUTERU</given-names></name><xref rid="af2-br-02-05-0644" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author">
<name><surname>KATO</surname><given-names>YUKIO</given-names></name><xref rid="af3-br-02-05-0644" ref-type="aff">3</xref></contrib></contrib-group>
<aff id="af1-br-02-05-0644">
<label>1</label>Department of Pathology and Bioscience, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori 036-8562, Japan</aff>
<aff id="af2-br-02-05-0644">
<label>2</label>First Department of Pathology, Wakayama Medical University School of Medicine, Wakayama 641-0012, Japan</aff>
<aff id="af3-br-02-05-0644">
<label>3</label>Department of Dental and Medical Biochemistry, Hiroshima University Graduate School of Biomedical Science, Hiroshima 734-8553, Japan</aff>
<author-notes>
<corresp id="c1-br-02-05-0644">Correspondence to: Dr Fuyuki Sato, First Department of Pathology, Wakayama Medical University School of Medicine, 811-1 Kimiidera, Wakayama 641-0012, Japan, E-mail: <email>fsatoDEC1DEC2@yahoo.co.jp</email></corresp></author-notes>
<pub-date pub-type="ppub">
<month>9</month>
<year>2014</year></pub-date>
<pub-date pub-type="epub">
<day>27</day>
<month>06</month>
<year>2014</year></pub-date>
<volume>2</volume>
<issue>5</issue>
<fpage>644</fpage>
<lpage>648</lpage>
<history>
<date date-type="received">
<day>13</day>
<month>05</month>
<year>2014</year></date>
<date date-type="accepted">
<day>25</day>
<month>06</month>
<year>2014</year></date></history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2014, Spandidos Publications</copyright-statement>
<copyright-year>2014</copyright-year></permissions>
<abstract>
<p>The majority of cells are cultured with Dulbecco&#x02019;s modified Eagle&#x02019;s medium (DMEM) or RPMI supplemented with fetal bovine serum (FBS), which contains numerous factors, including cytokines, nutrients and unknown growth factors. These factors may affect cell growth, apoptosis and differentiation. The serum-free medium, STK2, has been previously reported as suitable for the cell culture of human mesenchymal stem cells. However, how STK1 or STK2 affect the cell proliferation of normal and cancer cells remains unknown. The present study examined the growth of the human gingival fibroblast (HGF-1) cell-line and the HSC-3, CA9-22 and MSTO cancer cell-lines, cultured with STK1 and STK2. STK1 increased the cell proliferation of HGF-1 compared to DMEM by assessment with the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)- 2H-tetrazolium (MTS) assay, whereas STK1 and STK2 markedly inhibited the cell proliferation of HSC-3 and MSTO. The cell proliferation rate of CA9-22 cultured with STK1 or STK2 for 96 h was ~2-fold higher than the rate for 24 h culture. The shape of the HSC-3 cells was also found to have changed to round when cultured with STK2. These results indicate that STK1 increased the cell proliferation of HGF-1 compared to DMEM, whereas the proliferation of HSC-3 and MSTO was inhibited by STK1 and STK2. Thus, STK1 and STK2 had different affects on the cell growth of HGF-1, CA9-22, HSC-3 and MSTO.</p></abstract>
<kwd-group>
<kwd>STK1</kwd>
<kwd>STK2</kwd>
<kwd>fetal bovine serum</kwd>
<kwd>fetal calf serum</kwd>
<kwd>MTS assay</kwd></kwd-group></article-meta></front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Fetal bovine or calf serum (FBS or FCS, respectively) includes unspecified amounts of growth factors, which may modify the immune response and cell differentiation (<xref rid="b1-br-02-05-0644" ref-type="bibr">1</xref>&#x02013;<xref rid="b4-br-02-05-0644" ref-type="bibr">4</xref>). In addition, cell growth and differentiation may be affected in cell culture, depending on the amount of FBS or FCS present.</p>
<p>A previous study demonstrated that FBS inhibited cell growth and increased apoptosis (<xref rid="b4-br-02-05-0644" ref-type="bibr">4</xref>). Compared to FBS-supplemented media, serum-free media does not differ between individual batches, and thus, it may be suitable for the cell culture performance. There are several types of serum-free media, specific media is suitable for stem cells and others are acceptable for primary cell culture (<xref rid="b5-br-02-05-0644" ref-type="bibr">5</xref>,<xref rid="b6-br-02-05-0644" ref-type="bibr">6</xref>). These serum-free media do not affect cell growth and differentiation in cell culture. STK2 is a serum-free medium that has been developed for use with human mesenchymal stem cells (hMSC) (<xref rid="b7-br-02-05-0644" ref-type="bibr">7</xref>). STK2 had a minimal effect on the gene expression and morphology of hMSC after 50 days of culture, whereas Dulbecco&#x02019;s modified Eagle&#x02019;s medium (DMEM) with 10&#x00025; FBS significantly changed the expression of ~1,000 genes and the cell morphology (<xref rid="b7-br-02-05-0644" ref-type="bibr">7</xref>). Although STK2 is suitable for hMSC culture, it remains unknown whether STK2 can promote the growth of normal and cancer cells.</p>
<p>CA9-22 and HSC-3 are human oral squamous cell carcinoma cell lines that are often used for <italic>in vitro</italic> assays. CA9-22 highly expresses epidermal growth factor receptor (EGFR), whereas HSC-3 is prone to lymph node metastasis (<xref rid="b8-br-02-05-0644" ref-type="bibr">8</xref>,<xref rid="b9-br-02-05-0644" ref-type="bibr">9</xref>). Compared to HSC-3, it appears likely that histone deacetylase 2 is highly expressed in CA9-22 (<xref rid="b10-br-02-05-0644" ref-type="bibr">10</xref>). MSTO is a human malignant mesothelioma cell-line that highly expresses EGFR (<xref rid="b11-br-02-05-0644" ref-type="bibr">11</xref>). These cells have been cultured previously using general medium with 10&#x00025; FBS (<xref rid="b12-br-02-05-0644" ref-type="bibr">12</xref>&#x02013;<xref rid="b14-br-02-05-0644" ref-type="bibr">14</xref>). The present study aimed to examine how STK1 or STK2 affected the cell growth of human gingival fibroblasts (HGF-1), CA9-22, HSC-3 and MSTO by the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxy- methoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay. STK1 increased the proliferation of HGF-1 compared to DMEM, whereas STK1 and STK2 inhibited the proliferation of HSC-3 and MSTO. CA9-22 was able to grow with STK, but the proliferation rate of CA9-22 cultured with STK was lower than with DMEM. These results indicate that STK affects cell growth in the different cell lines, HGF-1, CA9-22, HSC-3 and MSTO.</p></sec>
<sec sec-type="materials|methods">
<title>Materials and methods</title>
<sec>
<title>Cell culture</title>
<p>HGF-1 and MSTO mesothelioma cells were obtained from the American Type Culture Collection (Manassas, VA, USA). CA9-22 and HSC-3 human oral cancer cell lines were obtained from the Japanese Cancer Research Resources Bank (Tokyo, Japan). These cells were cultured with DMEM-high glucose (Sigma-Aldrich, St Louis, MO, USA) supplemented with 10&#x00025; FBS, STK1 or STK2 serum-free media (DS Pharma Biomedical Co., Ltd., Osaka, Japan) at 37&#x000B0;C in a humidified atmosphere of 95&#x00025; air and 5&#x00025; CO<sub>2</sub>. Images of the cells were captured using a Zeiss microscope (Carl Zeiss, Oberkochen, Germany).</p></sec>
<sec>
<title>Cell viability assay</title>
<p>The cell viability assay was performed using the MTS assay. The cells were seeded in 96-well plates. After culturing for 24 h, the culture medium was changed to DMEM, STK1 or STK2, and the culture was continued for 96 h. CellTiter 96<sup>&#x000AE;</sup> AQ<sub>ueous</sub> One Solution reagent (Promega Corporation, Madison, WI, USA) was added to each well and the cells were incubated at 37&#x000B0;C for 1 h. The absorbance (OD<sub>490</sub> nm) was measured using a 96-well plate reader of iMark Microplate Absorbance Reader (Bio-Rad, Tokyo, Japan).</p></sec>
<sec>
<title>Statistical analysis</title>
<p>The data are provided as mean &#x000B1; standard deviation. Student&#x02019;s t-test was used for statistical analysis (P&lt;0.05).</p></sec></sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title>STK inhibits the cell proliferation of HSC-3 and MSTO</title>
<p>The affect of STK1 or STK2 was examined with regards to the cell growth of normal and cancer cells by the MTS assay. HGF-1, CA9-22, HSC-3 and MSTO cells were cultured with DMEM, STK1, or STK2 for 24&#x02013;96 h. The cell proliferation of HSC-3 at 96 h after the medium was changed was markedly inhibited by STK1 and STK2. For MSTO, some floating cells were observed when cultured with STK1 (<xref rid="f1-br-02-05-0644" ref-type="fig">Fig. 1A</xref>). STK2 also affected the cell morphology of HSC-3, which changed to a round shape (<xref rid="f1-br-02-05-0644" ref-type="fig">Fig. 1B</xref>). The cell proliferation rates of HGF-1 cultured with DMEM, STK1 and STK2 were 1.4, 2.0 and 1.7-fold, respectively (<xref rid="f2-br-02-05-0644" ref-type="fig">Fig. 2</xref>). There was a significant increase in the cell proliferation rate between DMEM and STK1 (P&lt;0.05), whereas there was no significant difference between DMEM and STK2 or STK1 and STK2. The cell proliferation rates of CA9-22 cultured with DMEM, STK1 and STK2 were 2.7, 2.0 and 2.1-fold, respectively. There was a significant decrease in the cell proliferation rate between DMEM and STK1, or DMEM and STK2 (P&lt;0.05), whereas there was no significant difference in the cell proliferation rate between STK1 and STK2. The cell proliferation rates of HSC-3 cultured with DMEM, STK1 and STK2 were 2.3, 0.8 and 0.5-fold, respectively. There were significant decreases in the cell proliferation rates between DMEM and STK1, between DMEM and STK2 (P&lt;0.05), and between STK1 and STK2 (P&lt;0.05). The cell proliferation rates of MSTO cultured with DMEM, STK1 and STK2 were 2.1, 0.7 and 0.9-fold, respectively. There were significant decreases in the cell proliferation rates between DMEM and STK1, and DMEM and STK2 (P&lt;0.05), and there was also a significant increase in the cell proliferation rate between STK1 and STK2 (P&lt;0.05).</p></sec></sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>Previously, certain studies have performed cell culture without FBS or FCS for pre-clinical data or embryonic stem cells, as the serum affects the cell culture performance (<xref rid="b15-br-02-05-0644" ref-type="bibr">15</xref>&#x02013;<xref rid="b17-br-02-05-0644" ref-type="bibr">17</xref>). STK1 and STK2 are serum-free media with unclear roles in the culture of normal and cancer cells. In the present study, the STK media were demonstrated to inhibit the cell proliferation of HSC-3 and MSTO, whereas they increased the cell proliferation of HGF-1 and CA9-22. When cultured with DMEM, these cancer cells grew well compared to STK1 and STK2. There are several possible explanations as to why STK media inhibited HSC-3 and MSTO cell proliferation. First, STK may have induced apoptosis or cell cycle arrest in HSC-3 and MSTO cells, as STK2 was found to induce a round shape in HSC-3. In addition, MTSO cultured with STK1 gave rise to a number of floating or detached cells. Whether this was due to apoptosis or detachment, and the explanation for why STK1 did not induce as many floating cells with HSC-3, could not be elucidated. STK1 may also possibly affect MSTO cell adhesion molecules, including &#x003B2;-catenin, claudins and E-cadherin (<xref rid="b18-br-02-05-0644" ref-type="bibr">18</xref>,<xref rid="b19-br-02-05-0644" ref-type="bibr">19</xref>).</p>
<p>CA9-22 and MSTO highly express EGFR, which may give rise to different proliferation rates between these two cell types when cultured with STK. Additionally, other factors may regulate cell proliferation, including the clock genes, <italic>PER1</italic> and <italic>PER3</italic>, which are closely associated with cisplatin-induced apoptosis in CA9-22 (<xref rid="b8-br-02-05-0644" ref-type="bibr">8</xref>,<xref rid="b20-br-02-05-0644" ref-type="bibr">20</xref>). PER1 is highly expressed in CA9-22, whereas it is weakly expressed in HGF-1. Deleted in esophageal cancer 1 (DEC1) regulates cell proliferation under a serum-free condition (<xref rid="b21-br-02-05-0644" ref-type="bibr">21</xref>). These molecules are closely associated with the regulation of apoptosis, cell cycle arrest and cell proliferation (<xref rid="b20-br-02-05-0644" ref-type="bibr">20</xref>,<xref rid="b22-br-02-05-0644" ref-type="bibr">22</xref>,<xref rid="b23-br-02-05-0644" ref-type="bibr">23</xref>). Therefore, it can be speculated that PER1, PER3 and DEC1 may be involved in the regulation of cell proliferation by STK. These studies indicate that HSC-3 and MSTO cells may require more nutritional components than HGF-1 and CA9-22. Therefore, future studies should clarify how STK affects apoptosis and the cell cycle.</p></sec></body>
<back>
<ack>
<title>Acknowledgements</title>
<p>The present study was supported in part by Grants-in-Aid for Science from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to Y.M. and Y.K.).</p></ack>
<ref-list>
<title>References</title>
<ref id="b1-br-02-05-0644"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kading</surname><given-names>VH</given-names></name><name><surname>Blalock</surname><given-names>JE</given-names></name><name><surname>Gifford</surname><given-names>GE</given-names></name></person-group><article-title>Effect of serum on the antiviral and anticellular activities of mouse interferon</article-title><source>Arch Virol</source><volume>56</volume><fpage>237</fpage><lpage>242</lpage><year>1978</year></element-citation></ref>
<ref id="b2-br-02-05-0644"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toldbod</surname><given-names>HE</given-names></name><name><surname>Agger</surname><given-names>R</given-names></name><name><surname>Bolund</surname><given-names>L</given-names></name><name><surname>Hokland</surname><given-names>M</given-names></name></person-group><article-title>Potent influence of bovine serum proteins in experimental dendritic cell-based vaccination protocols</article-title><source>Scand J Immunol</source><volume>58</volume><fpage>43</fpage><lpage>50</lpage><year>2003</year></element-citation></ref>
<ref id="b3-br-02-05-0644"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname><given-names>ZL</given-names></name><name><surname>Ju</surname><given-names>HP</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Gao</surname><given-names>TT</given-names></name><name><surname>Wang</surname><given-names>WB</given-names></name><name><surname>Aurelian</surname><given-names>L</given-names></name><name><surname>Zhao</surname><given-names>P</given-names></name><name><surname>Qi</surname><given-names>ZT</given-names></name></person-group><article-title>Fetal bovine serum inhibits hepatitis C virus attachment to host cells</article-title><source>J Virol Methods</source><volume>193</volume><fpage>261</fpage><lpage>269</lpage><year>2013</year></element-citation></ref>
<ref id="b4-br-02-05-0644"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberg</surname><given-names>K</given-names></name><name><surname>Ceder</surname><given-names>R</given-names></name><name><surname>Farnebo</surname><given-names>L</given-names></name><name><surname>Norberg-Spaak</surname><given-names>L</given-names></name><name><surname>Grafstr&#x000F6;m</surname><given-names>RC</given-names></name></person-group><article-title>Multiple genotypic aberrances associate to terminal differentiation-deficiency of an oral squamous cell carcinoma in serum-free culture</article-title><source>Differentiation</source><volume>76</volume><fpage>868</fpage><lpage>880</lpage><year>2008</year></element-citation></ref>
<ref id="b5-br-02-05-0644"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>ZZ</given-names></name><name><surname>Chen</surname><given-names>P</given-names></name><name><surname>Lu</surname><given-names>ZD</given-names></name><name><surname>Cui</surname><given-names>SD</given-names></name><name><surname>Dong</surname><given-names>ZM</given-names></name></person-group><article-title>Enrichment of breast cancer stem cells using a keratinocyte serum-free medium</article-title><source>Chin Med J (Engl)</source><volume>124</volume><fpage>2934</fpage><lpage>2936</lpage><year>2011</year></element-citation></ref>
<ref id="b6-br-02-05-0644"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mark</surname><given-names>P</given-names></name><name><surname>Kleinsorge</surname><given-names>M</given-names></name><name><surname>Gaebel</surname><given-names>R</given-names></name><name><surname>Lux</surname><given-names>CA</given-names></name><name><surname>Toelk</surname><given-names>A</given-names></name><name><surname>Pittermann</surname><given-names>E</given-names></name><name><surname>David</surname><given-names>R</given-names></name><name><surname>Steinhoff</surname><given-names>G</given-names></name><name><surname>Ma</surname><given-names>N</given-names></name></person-group><article-title>Human mesenchymal stem cells display reduced expression of CD105 after culture in serum-free medium</article-title><source>Stem Cells Int</source><volume>2013</volume><fpage>698076</fpage><year>2013</year></element-citation></ref>
<ref id="b7-br-02-05-0644"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sawada</surname><given-names>R</given-names></name><name><surname>Yamada</surname><given-names>T</given-names></name><name><surname>Tsuchiya</surname><given-names>T</given-names></name><name><surname>Matsuoka</surname><given-names>A</given-names></name></person-group><article-title>Microarray analysis of the effects of serum-free medium on gene expression changes in human mesenchymal stem cells during the in vitro culture</article-title><source>Yakugaku Zasshi</source><volume>130</volume><fpage>1387</fpage><lpage>1393</lpage><year>2010</year><comment>(In Japanese)</comment></element-citation></ref>
<ref id="b8-br-02-05-0644"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirai</surname><given-names>M</given-names></name><name><surname>Gamou</surname><given-names>S</given-names></name><name><surname>Minoshima</surname><given-names>S</given-names></name><name><surname>Shimizu</surname><given-names>N</given-names></name></person-group><article-title>Two independent mechanisms for escaping epidermal growth factor-mediated growth inhibition in epidermal growth factor receptor-hyperproducing human tumor cells</article-title><source>J Cell Biol</source><volume>107</volume><fpage>791</fpage><lpage>799</lpage><year>1988</year></element-citation></ref>
<ref id="b9-br-02-05-0644"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsui</surname><given-names>T</given-names></name><name><surname>Ota</surname><given-names>T</given-names></name><name><surname>Ueda</surname><given-names>Y</given-names></name><name><surname>Tanino</surname><given-names>M</given-names></name><name><surname>Odashima</surname><given-names>S</given-names></name></person-group><article-title>Isolation of a highly metastatic cell line to lymph node in human oral squamous cell carcinoma by orthotopic implantation in nude mice</article-title><source>Oral Oncol</source><volume>34</volume><fpage>253</fpage><lpage>256</lpage><year>1998</year></element-citation></ref>
<ref id="b10-br-02-05-0644"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>CC</given-names></name><name><surname>Lin</surname><given-names>BR</given-names></name><name><surname>Chen</surname><given-names>ST</given-names></name><name><surname>Hsieh</surname><given-names>TH</given-names></name><name><surname>Li</surname><given-names>YJ</given-names></name><name><surname>Kuo</surname><given-names>MY</given-names></name></person-group><article-title>HDAC2 promotes cell migration/invasion abilities through HIF-1&#x003B1; stabilization in human oral squamous cell carcinoma</article-title><source>J Oral Pathol Med</source><volume>40</volume><fpage>567</fpage><lpage>575</lpage><year>2011</year></element-citation></ref>
<ref id="b11-br-02-05-0644"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>J&#x000E4;nne</surname><given-names>PA</given-names></name><name><surname>Taffaro</surname><given-names>ML</given-names></name><name><surname>Salgia</surname><given-names>R</given-names></name><name><surname>Johnson</surname><given-names>BE</given-names></name></person-group><article-title>Inhibition of epidermal growth factor receptor signaling in malignant pleural mesothelioma</article-title><source>Cancer Res</source><volume>62</volume><fpage>5242</fpage><lpage>5247</lpage><year>2002</year></element-citation></ref>
<ref id="b12-br-02-05-0644"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bourguignon</surname><given-names>LY</given-names></name><name><surname>Earle</surname><given-names>C</given-names></name><name><surname>Wong</surname><given-names>G</given-names></name><name><surname>Spevak</surname><given-names>CC</given-names></name><name><surname>Krueger</surname><given-names>K</given-names></name></person-group><article-title>Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells</article-title><source>Oncogene</source><volume>31</volume><fpage>149</fpage><lpage>160</lpage><year>2012</year></element-citation></ref>
<ref id="b13-br-02-05-0644"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>K</given-names></name><name><surname>Tominaga</surname><given-names>K</given-names></name><name><surname>Sukedai</surname><given-names>M</given-names></name><name><surname>Okinaga</surname><given-names>T</given-names></name><name><surname>Iwanaga</surname><given-names>K</given-names></name><name><surname>Nishihara</surname><given-names>T</given-names></name><name><surname>Fukuda</surname><given-names>J</given-names></name></person-group><article-title>Delivery of cytolethal distending toxin B induces cell cycle arrest and apoptosis in gingival squamous cell carcinoma in vitro</article-title><source>Eur J Oral Sci</source><volume>112</volume><fpage>445</fpage><lpage>451</lpage><year>2004</year></element-citation></ref>
<ref id="b14-br-02-05-0644"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiang</surname><given-names>SL</given-names></name><name><surname>Jiang</surname><given-names>SS</given-names></name><name><surname>Wang</surname><given-names>YJ</given-names></name><name><surname>Chiang</surname><given-names>HC</given-names></name><name><surname>Chen</surname><given-names>PH</given-names></name><name><surname>Tu</surname><given-names>HP</given-names></name><name><surname>Ho</surname><given-names>KY</given-names></name><name><surname>Tsai</surname><given-names>YS</given-names></name><name><surname>Chang</surname><given-names>IS</given-names></name><name><surname>Ko</surname><given-names>YC</given-names></name></person-group><article-title>Characterization of arecoline-induced effects on cytotoxicity in normal human gingival fibroblasts by global gene expression profiling</article-title><source>Toxicol Sci</source><volume>100</volume><fpage>66</fpage><lpage>74</lpage><year>2007</year></element-citation></ref>
<ref id="b15-br-02-05-0644"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SJ</given-names></name><name><surname>Diamond</surname><given-names>B</given-names></name></person-group><article-title>Generation and maturation of bone marrow-derived DCs under serum-free conditions</article-title><source>J Immunol Methods</source><volume>323</volume><fpage>101</fpage><lpage>108</lpage><year>2007</year></element-citation></ref>
<ref id="b16-br-02-05-0644"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Yokohama-Tamaki</surname><given-names>T</given-names></name><name><surname>Tanaka</surname><given-names>TS</given-names></name></person-group><article-title>Short-term serum-free culture reveals that inhibition of Gsk3&#x003B2; induces the tumor-like growth of mouse embryonic stem cells</article-title><source>PLoS One</source><volume>6</volume><fpage>e21355</fpage><year>2011</year></element-citation></ref>
<ref id="b17-br-02-05-0644"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Millington</surname><given-names>M</given-names></name><name><surname>Arndt</surname><given-names>A</given-names></name><name><surname>Boyd</surname><given-names>M</given-names></name><name><surname>Applegate</surname><given-names>T</given-names></name><name><surname>Shen</surname><given-names>S</given-names></name></person-group><article-title>Towards a clinically relevant lentiviral transduction protocol for primary human CD34 hematopoietic stem/progenitor cells</article-title><source>PLoS One</source><volume>4</volume><fpage>e6461</fpage><year>2009</year></element-citation></ref>
<ref id="b18-br-02-05-0644"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fassina</surname><given-names>A</given-names></name><name><surname>Cappellesso</surname><given-names>R</given-names></name><name><surname>Guzzardo</surname><given-names>V</given-names></name><name><surname>Dalla Via</surname><given-names>L</given-names></name><name><surname>Piccolo</surname><given-names>S</given-names></name><name><surname>Ventura</surname><given-names>L</given-names></name><name><surname>Fassan</surname><given-names>M</given-names></name></person-group><article-title>Epithelial-mesenchymal transition in malignant mesothelioma</article-title><source>Mod Pathol</source><volume>25</volume><fpage>86</fpage><lpage>99</lpage><year>2012</year></element-citation></ref>
<ref id="b19-br-02-05-0644"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikari</surname><given-names>A</given-names></name><name><surname>Atomi</surname><given-names>K</given-names></name><name><surname>Takiguchi</surname><given-names>A</given-names></name><name><surname>Yamazaki</surname><given-names>Y</given-names></name><name><surname>Hayashi</surname><given-names>H</given-names></name><name><surname>Hirakawa</surname><given-names>J</given-names></name><name><surname>Sugatani</surname><given-names>J</given-names></name></person-group><article-title>Enhancement of cell-cell contact by claudin-4 in renal epithelial Madin-Darby canine kidney cells</article-title><source>J Cell Biochem</source><volume>113</volume><fpage>499</fpage><lpage>507</lpage><year>2012</year></element-citation></ref>
<ref id="b20-br-02-05-0644"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>F</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Bhawal</surname><given-names>UK</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Imaizumi</surname><given-names>T</given-names></name><name><surname>Morohashi</surname><given-names>S</given-names></name><name><surname>Kato</surname><given-names>Y</given-names></name><name><surname>Kijima</surname><given-names>H</given-names></name></person-group><article-title>PERIOD1 (PER1) has anti-apoptotic effects, and PER3 has pro-apoptotic effects during cisplatin (CDDP) treatment in human gingival cancer CA9-22 cells</article-title><source>Eur J Cancer</source><volume>47</volume><fpage>1747</fpage><lpage>1758</lpage><year>2011</year></element-citation></ref>
<ref id="b21-br-02-05-0644"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Xie</surname><given-names>M</given-names></name><name><surname>Hu</surname><given-names>M</given-names></name><name><surname>Ge</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>D</given-names></name><name><surname>Wan</surname><given-names>Y</given-names></name><name><surname>Yan</surname><given-names>B</given-names></name></person-group><article-title>Abundant expression of Dec1/stra13/sharp2 in colon carcinoma: its antagonizing role in serum deprivation-induced apoptosis and selective inhibition of procaspase activation</article-title><source>Biochem J</source><volume>367</volume><fpage>413</fpage><lpage>422</lpage><year>2002</year></element-citation></ref>
<ref id="b22-br-02-05-0644"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhawal</surname><given-names>UK</given-names></name><name><surname>Sato</surname><given-names>F</given-names></name><name><surname>Arakawa</surname><given-names>Y</given-names></name><name><surname>Fujimoto</surname><given-names>K</given-names></name><name><surname>Kawamoto</surname><given-names>T</given-names></name><name><surname>Tanimoto</surname><given-names>K</given-names></name><name><surname>Ito</surname><given-names>Y</given-names></name><name><surname>Sasahira</surname><given-names>T</given-names></name><name><surname>Sakurai</surname><given-names>T</given-names></name><name><surname>Kobayashi</surname><given-names>M</given-names></name><etal/></person-group><article-title>Basic helix-loop-helix transcription factor DEC1 negatively regulates cyclin D1</article-title><source>J Pathol</source><volume>224</volume><fpage>420</fpage><lpage>429</lpage><year>2011</year></element-citation></ref>
<ref id="b23-br-02-05-0644"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gery</surname><given-names>S</given-names></name><name><surname>Komatsu</surname><given-names>N</given-names></name><name><surname>Baldjyan</surname><given-names>L</given-names></name><name><surname>Yu</surname><given-names>A</given-names></name><name><surname>Koo</surname><given-names>D</given-names></name><name><surname>Koeffler</surname><given-names>HP</given-names></name></person-group><article-title>The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells</article-title><source>Mol Cell</source><volume>22</volume><fpage>375</fpage><lpage>382</lpage><year>2006</year></element-citation></ref></ref-list></back>
<floats-group>
<fig id="f1-br-02-05-0644" position="float">
<label>Figure 1</label>
<caption>
<p>Dulbecco&#x02019;s modified Eagle&#x02019;s medium (DMEM), STK1 and STK2 show differential effects on cell proliferation. (A) Human gingival fibroblast (HGF-1), CA9-22, HSC-3 or MSTO cells were cultured in chamber slides. The culture medium was changed to DMEM, STK1, or STK2 after 24 h and the cells were cultured for an additional 96 h before fixation. (B) HSC-3 cells were cultured with DMEM or STK2 and were fixed. Images were captured in bright-field mode.</p></caption>
<graphic xlink:href="BR-02-05-0644-g00.gif"/></fig>
<fig id="f2-br-02-05-0644" position="float">
<label>Figure 2</label>
<caption>
<p>Quantification of human gingival fibroblast (HGF-1), CA9-22, HSC-3 and MSTO cell proliferation at 24 and 96 h when cultured with Dulbecco&#x02019;s modified Eagle&#x02019;s medium (DMEM), STK1 and STK2. The cells were cultured and the MTS-assay was performed. The left panel shows the raw cell proliferation data at 24 and 96 h of cell culture; the right panel shows the cell proliferation rate as determined by Ab490 nm at 96 h, divided by the value at 24 h.</p></caption>
<graphic xlink:href="BR-02-05-0644-g01.gif"/></fig></floats-group></article>
